Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Merck
Cipla
Federal Trade Commission
Cerilliant
Chubb
Novartis
McKinsey
QuintilesIMS

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,932,645

« Back to Dashboard

Summary for Patent: 3,932,645
Title: Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid
Abstract:Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acids as the active ingredient and methods of using same. The said ingredients are unsymmetrical 1,4-dihydropyridine 3,5-dicarboxylates which are substituted at position-4 of the dihydropyridine nucleus by phenyl which contains at least one nitro, cyano, azido, alkylthio, or alkylsulphonyl substituent. The compositions have a cardiovascular activity which makes them useful for effecting coronary vascular dilation and, also, they have utility in the treatment of hypertension.
Inventor(s): Meyer; Horst (Wuppertal-Elberfeld, DT), Bossert; Friedrich (Wuppertal-Elberfeld, DT), Vater; Wulf (Opladen, DT), Stoepel; Kurt (Wuppertal-Vohwinkel, DT)
Assignee: Farbenfabriken Bayer AG (DT)
Application Number:05/398,982
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 3,932,645

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 3,932,645

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
2117571Apr 10, 1971

International Patents Family Members for US Patent 3,932,645

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 315178 ➤ Subscribe
Austria 316551 ➤ Subscribe
Austria 316552 ➤ Subscribe
Australia 4045472 ➤ Subscribe
Australia 4045572 ➤ Subscribe
Australia 459338 ➤ Subscribe
Australia 464663 ➤ Subscribe
Belgium 781878 ➤ Subscribe
Belgium 781879 ➤ Subscribe
Bulgaria 19374 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Farmers Insurance
QuintilesIMS
Johnson and Johnson
Accenture
Federal Trade Commission
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot